Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Microenvironment Induced Myelodysplastic Syndrome (MDS) in S100A9 Transgenic Mice Caused by Myeloid-Derived Suppressor Cells (MDSC)

Sheng Wei, MD, Xianghong Chen, Junmin Zhou, Ph.D, Ling Zhang, MD, Nicole R. Fortenbery, Sarah S Rasche, Ph.D, Kathy McGraw, Erika A. Eksioglu, Ph.D, P.K. Epling-Burnette, PhD, Julie Y. Djeu, Ph.D, Dmitry I. Gabrilovich, Ph.D, Alan F. List, MD

Blood (2011) 118 (21): 788.

https://doi.org/10.1182/blood.V118.21.788.788

Published: 2011

Journal Articles

Myeloid-Derived Suppressor Cells (MDSC) Are Effectors of Bone Marrow Suppression in Lower Risk Myelodysplastic Syndromes (MDS).

Sheng Wei, MD, Xianghong Chen, PhD, Kathy Rocha, Dahui Qi, MD, Jianguo Tao, MD, PhD, Nicole Gjertsen, Junmin Zhou, Ph.D, Jinhong Liu, M.D., Dmitry Gabrilovich, MD, PhD, P.K. Epling-Burnette, PhD, Julie Y Djeu, PhD, Alan F. List, MD

Blood (2009) 114 (22): 597.

https://doi.org/10.1182/blood.V114.22.597.597

Published: 2009

Journal Articles

A critical role for DAP10 and DAP12 in CD8 + T cell–mediated tissue damage in large granular lymphocyte leukemia

Xianghong Chen, Fanqi Bai, Lubomir Sokol, Junmin Zhou, Amy Ren, Jeffrey S. Painter, Jinhong Liu, David A. Sallman, Y. Ann Chen, Jeffrey A. Yoder, Julie Y. Djeu, Thomas P. Loughran, Pearlie K. Epling-Burnette, Sheng Wei

Blood (2009) 113 (14): 3226–3234.

https://doi.org/10.1182/blood-2008-07-168245

Published: 2009

Journal Articles

Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling

P. K. Epling-Burnette, Lubomir Sokol, Xianhong Chen, Fanqi Bai, Junmin Zhou, Michelle A. Blaskovich, JianXiang Zou, Jeffrey S. Painter, Todd D. Edwards, Lynn Moscinski, Jeffrey A. Yoder, Julie Y. Djeu, Said Sebti, Thomas P. Loughran, Jr, Sheng Wei

Blood (2008) 112 (12): 4694–4698.

https://doi.org/10.1182/blood-2008-02-136382

Published: 2008

Includes: Supplemental data

Journal Articles

Genetic Disparities in Killer Cell Immunoglobulin-Like Receptors (KIR) and MHC Class I in Bone Marrow Failure Syndromes

P.K. Epling-Burnette, PhD, Jeffrey S. Painter, BS, H.-S. Lee, PhD, Jong Park, Michael Clemente, MS, Christine O’Keefe, MD, Tie-Ying Wei, BS, Sheng Wei, MD, Jaroslaw Maciejewski, Thomas P. Loughran, Jr., MD, Ron Paquette, MD, Alan F. List, MD, Julie Y Djeu, PhD

Blood (2008) 112 (11): 4121.

https://doi.org/10.1182/blood.V112.11.4121.4121

Published: 2008

Journal Articles

β 2 integrins separate graft-versus-host disease and graft-versus-leukemia effects

Yaming Liang, Chen Liu, Julie Y. Djeu, Bin Zhong, Thorsten Peters, Karin Scharffetter-Kochanek, Claudio Anasetti, Xue-Zhong Yu

Blood (2008) 111 (2): 954–962.

https://doi.org/10.1182/blood-2007-05-089573

Published: 2008

Journal Articles

Gene Dosage of the Cell Cycle Regulatory Phosphatases Cdc25C and PP2A Determines Sensitivity to Lenalidomide in del(5q) MDS.

Sheng Wei, MD, Kathy Rocha, BS, Ann Williams, Ph.D., Xianhong Chen, Ph.D, P.K. Burnette, Ph.D., Julie Y. Djeu, Ph.D., Qing Liu, Ph.D., John Byrd, M.D., Lubomir Sokol, M.D., Nick Lawrence, Ph.D., Roberta Pireddu, Ph.D, Gordon Dewald, Ph.D., Jaroslaw Maciejewski, M.D., Alan List, M.D.

Blood (2007) 110 (11): 118.

https://doi.org/10.1182/blood.V110.11.118.118

Published: 2007

Journal Articles

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

Pearlie K. Epling-Burnette, Fanqi Bai, Jeffrey S. Painter, Dana E. Rollison, Helmut R. Salih, Matthias Krusch, JianXiang Zou, Edna Ku, Bin Zhong, David Boulware, Lynn Moscinski, Sheng Wei, Julie Y. Djeu, Alan F. List

Blood (2007) 109 (11): 4816–4824.

https://doi.org/10.1182/blood-2006-07-035519

Published: 2007

Includes: Supplemental data

Journal Articles

Reduced Natural Killer Function Accompanies MDS Disease Progression and Is Restored by Lenalidomide (CC5013, Revlimid®) Via a Mechanism Divergent from Interleukin-2 (IL-2).

P.K. Epling-Burnette, PhD, Fanqi Bai, MD, Jeffrey S. Painter, BS, Rollison Dana, PhD, JianXiang Zou, MD, Edna Ku, MD, Bin Zhong, BS, Sheng Wei, MD, Julie Y. Djeu, PhD, Alan F. List, MD

Blood (2006) 108 (11): 2651.

https://doi.org/10.1182/blood.V108.11.2651.2651

Published: 2006

Journal Articles

Natural Killer Cells with NKDG2D Cytotoxicity but NKp30-Dull Phenotype Predominate in Myelodysplastic Syndrome (MDS).

Fanqi Bai, MD, Jeffrey S. Painter, Cantor Alan, PhD, Zou JianXiang, MD, Sheng Wei, MD, Julie Y. Djeu, PhD, Alan F. List, MD, P.K. Epling-Burnette, PhD

Blood (2005) 106 (11): 3436.

https://doi.org/10.1182/blood.V106.11.3436.3436

Published: 2005

Journal Articles

Lenalidomide Effects on NK Function in Patients with Myelodysplastic Syndrome (MDS).

P.K. Epling-Burnette, PhD, Fanqi Bai, MD, Jeffrey S. Painter, Julie Y. Djeu, PhD, Alan F. List, MD

Blood (2005) 106 (11): 3437.

https://doi.org/10.1182/blood.V106.11.3437.3437

Published: 2005

Journal Articles

Reduced Inhibitory KIR Receptors in Patients with NK-Lymphoproliferative Disease of Large Granular Lymphocytes (NK-LDGL) Leads to Dysregulated Killing.

P.K. Epling-Burnette, Ph.D., Fanqi Bai, M.D., Jeffrey S. Painter, B.S., Sheng Wei, M.D., Julie Y. Djeu, Ph.D., Thomas P. Loughran, M.D.

Blood (2004) 104 (11): 2661.

https://doi.org/10.1182/blood.V104.11.2661.2661

Published: 2004

Journal Articles

Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes

Pearlie Kay Epling-Burnette, Jeffrey S. Painter, Pratima Chaurasia, Fanqi Bai, Sheng Wei, Julie Y. Djeu, Thomas P. Loughran, Jr

Blood (2004) 103 (9): 3431–3439.

https://doi.org/10.1182/blood-2003-02-0400

Published: 2004

Journal Articles

Regulation of Akt-dependent cell survival by Syk and Rac

Kun Jiang, Bin Zhong, Connie Ritchey, Danielle L. Gilvary, Elizabeth Hong-Geller, Sheng Wei, Julie Y. Djeu

Blood (2003) 101 (1): 236–244.

https://doi.org/10.1182/blood-2002-04-1251

Published: 2003

Journal Articles

Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia

Jin Hong Liu, Sheng Wei, Thierry Lamy, Yongxiang Li, P.K. Epling-Burnette, Julie Y. Djeu, Thomas P. Loughran, Jr

Blood (2002) 100 (4): 1449–1453.

https://doi.org/10.1182/blood.V100.4.1449.h81602001449_1449_1453

Published: 2002

Journal Articles

Chronic neutropenia mediated by Fas ligand

Jin Hong Liu, Sheng Wei, Thierry Lamy, P. K. Epling-Burnette, Gordon Starkebaum, Julie Y. Djeu, Thomas P. Loughran, Jr

Blood (2000) 95 (10): 3219–3222.

https://doi.org/10.1182/blood.V95.10.3219

Published: 2000

NARROW

Microenvironment Induced Myelodysplastic Syndrome (MDS) in S100A9 Transgenic Mice Caused by Myeloid-Derived Suppressor Cells (MDSC)

Myeloid-Derived Suppressor Cells (MDSC) Are Effectors of Bone Marrow Suppression in Lower Risk Myelodysplastic Syndromes (MDS).

A critical role for DAP10 and DAP12 in CD8 + T cell–mediated tissue damage in large granular lymphocyte leukemia

Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling

Genetic Disparities in Killer Cell Immunoglobulin-Like Receptors (KIR) and MHC Class I in Bone Marrow Failure Syndromes

β 2 integrins separate graft-versus-host disease and graft-versus-leukemia effects

Gene Dosage of the Cell Cycle Regulatory Phosphatases Cdc25C and PP2A Determines Sensitivity to Lenalidomide in del(5q) MDS.

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

Reduced Natural Killer Function Accompanies MDS Disease Progression and Is Restored by Lenalidomide (CC5013, Revlimid®) Via a Mechanism Divergent from Interleukin-2 (IL-2).

Natural Killer Cells with NKDG2D Cytotoxicity but NKp30-Dull Phenotype Predominate in Myelodysplastic Syndrome (MDS).

Lenalidomide Effects on NK Function in Patients with Myelodysplastic Syndrome (MDS).

Reduced Inhibitory KIR Receptors in Patients with NK-Lymphoproliferative Disease of Large Granular Lymphocytes (NK-LDGL) Leads to Dysregulated Killing.

Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes

Regulation of Akt-dependent cell survival by Syk and Rac

Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia

Chronic neutropenia mediated by Fas ligand

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only